TABLE 6.
Smear value | No. of specimens with smear value
|
|||
---|---|---|---|---|
NALC/NaOH
|
CB-18
|
|||
AFB positive | AFB negative | AFB positive | AFB negative | |
− | 28 | 506 | 37 | 439 |
± | 3 | 0 | 5 | 25d |
1+ | 7 | 1b | 8 | 14e |
2+ | 8 | 1c | 6 | 2f |
3+ | 5 | 0 | 7 | 0 |
4+ | 14 | 0 | 30 | 0 |
Total | 65 | 508 | 93 | 480 |
In this analysis, the smear and culture data from NALC/NaOH-processed specimens were considered independent of the results generated from CB-18 processing (e.g., all smear and culture results generated from processing with CB-18 were ignored), and the results were first segregated as either NALC/NaOH culture positive or NALC/NaOH culture negative. The smear results after NALC/NaOH processing were then overlaid on these culture results to categorize the specimen data. The analogous breakdown was then performed with results from processing with CB-18. The smear sensitivities (AFB positive) were 56.9% for NALC/NaOH and 60.2% for CB-18. The smear specificities (AFB negative) were 99.6% for NALC/NaOH and 91.5% for CB-18.
This specimen was from a patient previously culture positive for MAC and Nocardia sp. This specimen was also culture positive for MAC when processed by the CB-18 method.
This specimen was from a patient previously positive for MTBC. In addition, this specimen was also 2+ smear positive when processed by the CB-18 method.
One of these specimens was culture positive for M. gastri, and two of these specimens were culture positive for MTBC when processed with NALC/NaOH.
One of these specimens was culture positive for MTBC when processed with NALC/NaOH.
One of these specimens was from a patient previously positive for MTBC. The same specimen was also 2+ smear positive and culture negative when processed with NALC/NaOH.